Cynosure Group’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.54M Sell
5,235
-1,449
-22% -$440K 0.19% 46
2025
Q4
$2.15M Sell
6,684
-6,018
-47% -$1.86M 0.22% 48
2025
Q3
$4.01M Sell
12,702
-3,005
-19% -$894K 0.44% 32
2025
Q2
$4.55M Buy
15,707
+424
+3% +$108K 0.52% 27
2025
Q1
$3.75M Buy
15,283
+472
+3% +$120K 0.52% 27
2024
Q4
$3.55M Sell
14,811
-2,731
-16% -$636K 0.53% 29
2024
Q3
$3.7M Buy
17,542
+422
+2% +$88.9K 0.54% 31
2024
Q2
$3.46M Buy
17,120
+969
+6% +$189K 0.56% 29
2024
Q1
$3.24M Buy
16,151
+5,702
+55% +$1.03M 0.58% 27
2023
Q4
$1.78M Buy
10,449
+332
+3% +$50.3K 0.32% 70
2023
Q3
$1.47M Buy
10,117
+632
+7% +$94.7K 0.45% 52
2023
Q2
$1.38M Buy
+9,485
New +$1.3M 0.41% 55
2020
Q2
Sell
-22,556
Closed -$2.03M 39
2020
Q1
$2.03M Buy
22,556
+14,931
+196% +$1.81M 1.45% 17
2019
Q4
$1.06M Hold
7,625
0.57% 14
2019
Q3
$897K Sell
7,625
-2,697
-26% -$305K 0.49% 18
2019
Q2
$1.15M Buy
+10,322
New +$1.14M 0.53% 17

Other funds holding JPM

Cynosure Group's JPM Position: Q1 2026 in Review

Cynosure Group reduced its JPMorgan Chase (JPM) stake by 22% in Q1 2026, selling an estimated $440K and leaving 5,235 shares worth $1.54M. The position accounts for 0.19% of the portfolio, ranked #46.

Cynosure Group first reported a position in JPM in Q2 2019 and has held it in 16 quarters since. The position peaked at $4.55M in Q2 2025. 5,054 funds tracked by Wall St. Rank hold JPM as of Q1 2026.

  • Cynosure Group held 5,235 shares of JPMorgan Chase worth $1.54M as of Q1 2026.
  • Cynosure Group sold 1,449 JPMorgan Chase shares in Q1 2026, an estimated $440K.
  • JPMorgan Chase made up 0.19% of Cynosure Group's portfolio in Q1 2026, its #46 holding.
  • Cynosure Group first reported a position in JPMorgan Chase in Q2 2019 and has held it in 16 quarters since.
  • Cynosure Group's JPMorgan Chase position peaked at $4.55M in Q2 2025.
  • 5,054 funds tracked by Wall St. Rank held JPMorgan Chase as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.